Glenmark Pharmaceuticals Limited (GLENMARK.NS)
INR 1541.1
(1.08%)
INR 1541.1
(1.08%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 12.3 Billion INR | -73.4% |
| 2022 | 46.27 Billion INR | 16.79% |
| 2021 | 39.62 Billion INR | -20.53% |
| 2020 | 49.85 Billion INR | -3.86% |
| 2019 | 51.85 Billion INR | 16.57% |
| 2018 | 44.48 Billion INR | -4.11% |
| 2017 | 46.39 Billion INR | -1.78% |
| 2016 | 47.23 Billion INR | 18.44% |
| 2015 | 39.88 Billion INR | 4.95% |
| 2014 | 37.99 Billion INR | 16.31% |
| 2013 | 32.66 Billion INR | 18.16% |
| 2012 | 27.64 Billion INR | 23.18% |
| 2011 | 22.44 Billion INR | 6.29% |
| 2010 | 21.11 Billion INR | 12.96% |
| 2009 | 18.69 Billion INR | -10.74% |
| 2008 | 20.94 Billion INR | 111.35% |
| 2007 | 9.9 Billion INR | 5.79% |
| 2006 | 9.36 Billion INR | 27.37% |
| 2005 | 7.35 Billion INR | 68.1% |
| 2004 | 4.37 Billion INR | 280.83% |
| 2003 | 1.14 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 12.3 Billion INR | -73.4% |
| 2023 Q2 | 51.81 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 12.3 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 42.39 Billion INR | 0.0% |
| 2022 Q4 | 46.27 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 46.27 Billion INR | 16.79% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 39.62 Billion INR | 0.0% |
| 2021 Q2 | 38.96 Billion INR | 0.0% |
| 2021 FY | 39.62 Billion INR | -20.53% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 49.85 Billion INR | -3.86% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 29.58 Billion INR | 0.0% |
| 2020 Q4 | 49.85 Billion INR | 0.0% |
| 2019 FY | 51.85 Billion INR | 16.57% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 51.85 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 35.19 Billion INR | 0.0% |
| 2018 FY | 44.48 Billion INR | -4.11% |
| 2018 Q4 | 44.48 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 44.27 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 46.39 Billion INR | -1.78% |
| 2017 Q4 | 46.39 Billion INR | 0.0% |
| 2017 Q2 | 44.98 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 FY | 47.23 Billion INR | 18.44% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 57 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 47.23 Billion INR | 0.0% |
| 2015 FY | 39.88 Billion INR | 4.95% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 39.88 Billion INR | 0.0% |
| 2015 Q2 | 32.53 Billion INR | 0.0% |
| 2014 Q2 | 30.35 Billion INR | 0.0% |
| 2014 Q4 | 37.99 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 37.99 Billion INR | 16.31% |
| 2013 FY | 32.66 Billion INR | 18.16% |
| 2013 Q4 | 32.66 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 32.96 Billion INR | 0.0% |
| 2012 FY | 27.64 Billion INR | 23.18% |
| 2012 Q4 | 27.64 Billion INR | 0.0% |
| 2012 Q2 | - INR | 0.0% |
| 2012 Q3 | - INR | 0.0% |
| 2011 Q4 | 22.44 Billion INR | 0.0% |
| 2011 FY | 22.44 Billion INR | 6.29% |
| 2010 FY | 21.11 Billion INR | 12.96% |
| 2009 FY | 18.69 Billion INR | -10.74% |
| 2008 FY | 20.94 Billion INR | 111.35% |
| 2007 FY | 9.9 Billion INR | 5.79% |
| 2006 FY | 9.36 Billion INR | 27.37% |
| 2005 FY | 7.35 Billion INR | 68.1% |
| 2004 FY | 4.37 Billion INR | 280.83% |
| 2003 FY | 1.14 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | -760.479% |
| Ind-Swift Limited | 10.13 Billion INR | -21.394% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -269.844% |
| Sakar Healthcare Limited | 793.51 Million INR | -1451.235% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 81.483% |
| Innova Captab Limited | 2.45 Billion INR | -402.207% |
| Divi's Laboratories Limited | 30 Million INR | -40931.0% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -26669.823% |
| Morepen Laboratories Limited | 289.99 Million INR | -4144.703% |
| Mankind Pharma Limited | 2.07 Billion INR | -494.157% |
| Sequent Scientific Limited | 4.87 Billion INR | -152.399% |
| Wanbury Limited | 1.16 Billion INR | -956.732% |
| Laurus Labs Limited | 25.77 Billion INR | 52.241% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -93.684% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -7078.272% |
| Alembic Limited | 91.5 Million INR | -13352.787% |
| Hikal Limited | 8.17 Billion INR | -50.558% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -139.873% |
| Neuland Laboratories Limited | 953.89 Million INR | -1190.424% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -225.936% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -3657.418% |
| Themis Medicare Limited | 957.92 Million INR | -1185.0% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -53.063% |
| Lupin Limited | 29.21 Billion INR | 57.87% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -71122.01% |
| Wockhardt Limited | 23.56 Billion INR | 47.753% |
| Vaishali Pharma Limited | 134.91 Million INR | -9023.542% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -331.527% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -13667.252% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 66.405% |
| FDC Limited | 205.18 Million INR | -5899.123% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 38.515% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -3789.624% |
| Eris Lifesciences Limited | 27.81 Billion INR | 55.742% |
| Venus Remedies Limited | 413.3 Million INR | -2878.297% |
| ZIM Laboratories Limited | 1.08 Billion INR | -1031.116% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -1132.901% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -62383.756% |
| Shilpa Medicare Limited | 9.37 Billion INR | -31.315% |
| Albert David Limited | 33.24 Million INR | -36929.362% |
| Ajanta Pharma Limited | 352.8 Million INR | -3389.031% |
| Hester Biosciences Limited | 2.44 Billion INR | -403.699% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -1793.843% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -21.694% |
| Gufic Biosciences Limited | 3.32 Billion INR | -269.742% |
| Windlas Biotech Limited | 36.41 Million INR | -33707.47% |
| Procter & Gamble Health Limited | 95.6 Million INR | -12775.837% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -3826.123% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -1149.77% |
| Granules India Limited | 13.15 Billion INR | 6.398% |
| Aarti Drugs Limited | 5.64 Billion INR | -118.146% |
| Bal Pharma Limited | 1.39 Billion INR | -781.449% |
| Alkem Laboratories Limited | 14.18 Billion INR | 13.218% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 62.399% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -115285.264% |
| Medicamen Biotech Limited | 308.17 Million INR | -3894.295% |
| Unichem Laboratories Limited | 2.47 Billion INR | -397.317% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -4947.008% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -280357.963% |
| Valiant Laboratories Limited | 767.08 Million INR | -1504.687% |
| Orchid Pharma Limited | 1.35 Billion INR | -810.582% |
| Medico Remedies Limited | 80.5 Million INR | -15190.296% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -7305.605% |
| Ipca Laboratories Limited | 14.38 Billion INR | 14.421% |
| Brooks Laboratories Limited | 56.41 Million INR | -21717.65% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -1598.148% |
| Piramal Enterprises Limited | 535.85 Billion INR | 97.703% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 69.395% |
| NATCO Pharma Limited | 3.71 Billion INR | -231.608% |
| Suven Life Sciences Limited | 7.09 Million INR | -173343.709% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -536.371% |
| Strides Pharma Science Limited | 25.16 Billion INR | 51.093% |
| Indoco Remedies Limited | 6.71 Billion INR | -83.185% |
| Alpa Laboratories Limited | 52.46 Million INR | -23361.927% |
| Lasa Supergenerics Limited | 220.76 Million INR | -5475.824% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -1912.968% |